首页> 外文期刊>International Journal of Cardiology >Effect of renal insufficiency and diabetes mellitus on in-hospital mortality after acute coronary syndromes treated with primary PCI. Results from the ALKK PCI Registry
【24h】

Effect of renal insufficiency and diabetes mellitus on in-hospital mortality after acute coronary syndromes treated with primary PCI. Results from the ALKK PCI Registry

机译:肾功能不全和糖尿病对初级PCI处理后急性冠状动脉综合征后的住院死亡率的影响。 ALKK PCI注册表的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background: It is known that patients with acute coronary syndromes (ACS) and diabetes mellitus (DM) are at higher risk for in-hospital adverse events. However, we hypothesized that the higher event rate is due to the patients' subgroup with renal failure (RF), a common sequel of DM.Methods and results: We used data of the prospective ALKK-PCl registry including all consecutive percutaneous coronary interventions (PCI) for ACS of 48 hospitals between 2008 and 2013. We divided 69,651 patients in four groups according to their history of DM and RF (GFR < 60 ml/min). All-cause, in-hospital mortality of the following four groups: noDM/noRF, DM/noRF, DM/RF, RF/noDM, was: 3.5%, 6.6%, 21.9%, and 14.1% for STEMI and 1.5%, 2.1%, 7.2%, and 5.4% for NSTE-ACS. In a multivariate analysis we looked for independent mortality-predictors. Odds ratios with confidence intervals for the following variables: DM without RF, DM with RF, RF without DM were: 1.62 (1.37-1.90), 3.02 (2.43-3.76), and 2.13 (1.80-2.52) for STEMI and 1.20 (0.99-1.45), 2.72 (2.18-3.88), and 2.08 (1.69-2.56) for NSTE-ACS. We also calculated mortality in four groups (60-90,45-60,45-30, <30 ml/min) according to the estimated glomerular filtration rate (eGFR). Mortality rates were: 5.0%, 12.8%, 17.7%, and 31.5% for STEMI and 2.1%, 3.8%, 7.1%, and 12.0% for NSTE-ACS (p for trend <0.0001 for both).
机译:背景:众所周知,患有急性冠状动脉综合征(ACS)和糖尿病(DM)的患者处于院内不良事件的风险较高。然而,我们假设较高的事件率是由于患者的亚群,肾功能衰竭(RF),一种常见的DM.Methods和结果:我们使用了预期ALKK-PCL注册表的数据,包括所有连续经皮冠状动脉干预( PCI)2008年至2013年间48家医院的AC。根据其DM和RF的历史(GFR <60毫升/分钟),我们将69,651名患者分为四组。所有原因,中医院死亡率以下四组:Nodm / NoRF,DM / NORF,DM / RF,RF / NODM,STEMI的3.5%,6.6%,21.9%和14.1%, NSTE-AC的2.1%,7.2%和5.4%。在多变量分析中,我们寻找独立的死亡率预测。对于以下变量的置信区间的差距:DM没有RF,DM,RF,RF没有DM的RF为:1.62(1.37-1.90),3.02(2.43-3.76),3.02(2.43-3.76),2.13(1.80-2.52),用于Stemi和1.20(0.99 -1.45),2.72(2.18-3.88),2.08(1.69-2.56)用于NSTE-AC。根据估计的肾小球过滤速率(EGFR),我们还计算了四组的死亡率(60-90,45-60,45-30,<30ml / min)。 DIPI的死亡率为:5.0%,12.8%,17.7%和31.5%,NSTE-ACS的2.1%,3.8%,7.1%和12.0%(对于两者趋势<0.0001)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号